Detlef Dieckmann

4.4k total citations · 2 hit papers
22 papers, 3.6k citations indexed

About

Detlef Dieckmann is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Detlef Dieckmann has authored 22 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Detlef Dieckmann's work include Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (9 papers) and Mast cells and histamine (6 papers). Detlef Dieckmann is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (9 papers) and Mast cells and histamine (6 papers). Detlef Dieckmann collaborates with scholars based in Germany, United States and United Kingdom. Detlef Dieckmann's co-authors include Gerold Schuler, Thomas Berger, Susanne Berchtold, Eckhart Kämpgen, Petra Keikavoussi, Claudia Röder, Armin Bender, Beatrice Thurner, Manfred B. Lutz and Christian Maczek and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Detlef Dieckmann

22 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

1999 1.0k citations Beatrice Thurner, Ina Haendle et al. The Journal of Experimental Medicine profile →
Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

2001 935 citations Detlef Dieckmann, Susanne Berchtold et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Detlef Dieckmann

Since Specialization

Citations

This map shows the geographic impact of Detlef Dieckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Detlef Dieckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Detlef Dieckmann more than expected).

Fields of papers citing papers by Detlef Dieckmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Detlef Dieckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Detlef Dieckmann. The network helps show where Detlef Dieckmann may publish in the future.

Co-authorship network of co-authors of Detlef Dieckmann

This figure shows the co-authorship network connecting the top 25 collaborators of Detlef Dieckmann. A scholar is included among the top collaborators of Detlef Dieckmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Detlef Dieckmann. Detlef Dieckmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MHC‐peptide‐specific antibodies reveal inefficient presentation of an HLA‐A0201‐restricted, Melan‐A‐derived peptide after active intracellular processing 2007 ·European Journal of Immunology* ·Gerhard Held, Andreas Wadle, (unknown), Guillaume B. E. Stewart-Jones, (unknown), Markus Thiel, Carsten Zwick, Detlef Dieckmann, Gerold Schuler, Hennie R. Hoogenboom, Frédéric Lévy, Vincenzo Cerundolo, Michael Pfreundschuh, Christoph Renner	13
2	Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like Cells 2006 ·The Journal of Immunology ·Christian Veldman, Andreas Pahl, Stefan Beissert, Wiebke Hansen, Jan Buer, Detlef Dieckmann, Gerold Schuler, Michael Hertl	58
3	Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases 2006 ·Acta Neuropathologica ·Annett Hölsken, Ilker Y. Eyüpoglu, (unknown), Christian Tränkle, Detlef Dieckmann, Rolf Buslei, Eric Hahnen, Ingmar Blümcke, Florian A. Siebzehnrübl	14
4	Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation 2005 ·The Journal of Immunology ·Niels Schaft, Jan Dörrie, (unknown), Verena Beck, Ina Müller, Erwin Schultz, Eckhart Kämpgen, Detlef Dieckmann, Gerold Schuler	3
5	Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation 2005 ·The Journal of Immunology ·Niels Schaft, Jan Dörrie, (unknown), Verena Beck, Ina Müller, Erwin Schultz, Eckhart Kämpgen, Detlef Dieckmann, Gerold Schuler	115
6	Activated CD4⁺ CD25⁺ T cells suppress antigen‐specific CD4⁺ and CD8⁺ T cells but induce a suppressive phenotype only in CD4⁺ T cells 2005 ·Immunology ·Detlef Dieckmann, (unknown), (unknown), Gerold Schuler	30
7	Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris 2004 ·The Journal of Immunology ·Christian Veldman, (unknown), Detlef Dieckmann, Gerold Schuler, Michael Hertl	128
8	Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma 2003 ·Melanoma Research ·Dirk M. Nettelbeck, (unknown), Julia Davydova, Detlef Dieckmann, Masato Yamamoto, DT Curiel	19
9	Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single‐chain diabody (scDb) adapter that binds to fiber knob and HMWMAA 2003 ·International Journal of Cancer ·Dirk M. Nettelbeck, Ángel A. Rivera, (unknown), Detlef Dieckmann, Joanne T. Douglas, Roland E. Kontermann, Ramón Alemany, David T. Curiel	61
10	TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity 2002 ·The Journal of Immunology ·Patrick Chames, Ralph A. Willemsen, Gertrudis Rojas, Detlef Dieckmann, (unknown), Gerold Schuler, R. L. H. Bolhuis, Hennie R. Hoogenboom	64
11	Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells 2002 ·The Journal of Experimental Medicine ·Detlef Dieckmann, (unknown), (unknown), Manfred B. Lutz, Gerold Schuler	393
12	Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood breakdown → 2001 ·The Journal of Experimental Medicine ·Detlef Dieckmann, (unknown), Susanne Berchtold, Thomas Berger, Gerold Schuler	935
13	Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells 2000 ·The Journal of Immunology ·(unknown), Detlef Dieckmann, Petra Keikavoussi, Armin Bender, Christian Maczek, Helmut Jonuleit, Claudia Röder, Ina Haendle, (unknown), P. Rod Dunbar, Vincenzo Cerundolo, Peter Von Den Driesch, Jürgen Knop, Eva B. Bröcker, Alexander Enk, Eckhart Kämpgen, Gerold Schuler	173
14	Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application 1999 ·Journal of Immunological Methods ·Beatrice Thurner, Claudia Röder, Detlef Dieckmann, Marion Heuer, (unknown), A. Glaser, Petra Keikavoussi, Eckhart Kämpgen, Armin Bender, Gerold Schuler	421
15	Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma breakdown → 1999 ·The Journal of Experimental Medicine ·Beatrice Thurner, Ina Haendle, Claudia Röder, Detlef Dieckmann, Petra Keikavoussi, Helmut Jonuleit, Armin Bender, Christian Maczek, (unknown), Peter Von Den Driesch, Eva B. Bröcker, Ralph M. Steinman, Alexander Enk, Eckhart Kämpgen, Gerold Schuler	1020
16	Heterogeneity of Signal Transduction Mechanisms in Human Basophils and Human Skin Mast Cells 1997 ·Neurosignals ·(unknown), Detlef Dieckmann, Bernhard F. Gibbs, Martin Nitschke, Claudia Albrecht, (unknown), Tatsuya Tamaoki, Helmut H. Wolff, Ulrich Amon	6
17	Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells 1996 ·Archives of Dermatological Research ·Martin Nitschke, (unknown), Detlef Dieckmann, Bernhard F. Gibbs, (unknown), (unknown)	11
18	Heterogeneity of Human Skin Mast Cells and Human Basophils 1996 ·Skin Pharmacology and Physiology ·(unknown), Detlef Dieckmann, Martin Nitschke, Esther von Stebut, (unknown), (unknown)	3
19	Rolle der basophilen Leukozyten bei entz�ndlichen Hauterkrankungen 1995 ·Der Hautarzt ·Ulrich Amon, Detlef Dieckmann, Martin Nitschke, (unknown), Helmut H. Wolff	4
20	Activation and inhibition of mediator release from skin mast cells: a review of in vitro experiments 1994 ·Clinical & Experimental Allergy ·Ulrich Amon, Martin Nitschke, Detlef Dieckmann, Bernhard F. Gibbs, (unknown), Helmut H. Wolff	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact